US Broker Ratings

UFP Technologies (UFPT) Stock Analysis: 27% Potential Upside in the Medical Device Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands out as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.89 billion, UFPT has..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 38% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG) stands at the intersection of innovation and essential services in the healthcare sector. As a key player in the diagnostics and research industry, Neogen has carved..

CG Oncology, Inc. (CGON) Growth Potential: Exploring a 119.64% Upside Amidst Clinical Trials Success

CG Oncology, Inc. (CGON) is a biopharmaceutical company that has garnered significant attention in the healthcare sector, particularly in the biotechnology industry. Headquartered in Irvine, California, CG Oncology is at..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 159% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, PACS Group, Inc. (PACS) presents an intriguing proposition. Operating in the niche of skilled nursing and assisted living facilities, PACS is carving..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring the 22.37% Potential Upside for Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector, is capturing the attention of investors with its significant growth potential. With a market capitalization of $1.44 billion,..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), an influential player in the healthcare sector, specializes in providing cutting-edge biological and chemical compound sample exploration and management solutions. With its operations spanning globally, Azenta..

Twist Bioscience Corporation (TWST) Stock Analysis: Unlocking a 32% Potential Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector with its innovative approach to synthetic DNA products. Headquartered in South San Francisco, California, Twist Bioscience stands at..

Merus N.V. (MRUS) Stock Analysis: Exploring a 37% Upside in the Biotech Sector

The Netherlands-based Merus N.V. (NASDAQ: MRUS) is making waves in the biotechnology sector with its innovative approach to developing antibody therapeutics. As a clinical-stage immuno-oncology company, Merus is strategically positioned..

MannKind Corporation (MNKD): Analyst Ratings Highlight a Promising 130% Upside

MannKind Corporation (NASDAQ: MNKD), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and analyst ratings that suggest a significant upside potential. The..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Uncovering a Potential 314.93% Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Structure Therapeutics Inc. (NASDAQ: GPCR) presents a compelling case with a notable potential upside of 314.93%, based on current analyst ratings. As..

Amneal Pharmaceuticals, Inc. (AMRX): Investor Outlook with a 43.82% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is capturing the attention of investors with its promising growth potential. As a key manufacturer in the drug..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Potential 87% Upside in the Precision Medicine Space

Investors with an eye for innovation in the healthcare sector should closely monitor IDEAYA Biosciences, Inc. (NASDAQ: IDYA). The precision medicine oncology company, with a market capitalization of $2.19 billion,..

Beam Therapeutics Inc. (BEAM): Analyst Ratings Reveal 111% Potential Upside for Biotech Innovator

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of precision genetic medicines, stands at the forefront of the biotechnology industry with its innovative approaches to treating serious diseases...

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Evaluating a 27.97% Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a leading biopharmaceutical company specializing in the development of treatments for central nervous system (CNS) disorders and rare diseases, presents an intriguing investment opportunity with..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in the Dental Market

Envista Holdings Corporation (NYSE: NVST) stands as a significant player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. With a market capitalization of $3.52 billion, Envista..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Unpacking a 31.79% Potential Upside in Healthcare Investments

Guardian Pharmacy Services, Inc (GRDN) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.31 billion, this U.S.-based..

89bio, Inc. (ETNB) Investor Outlook: A Biotech Stock with a 208.91% Potential Upside

Investors seeking opportunities in the biotechnology sector may find 89bio, Inc. (ETNB) an intriguing prospect. With a market capitalization of $1.39 billion, this San Francisco-based clinical-stage biopharmaceutical company focuses on..

Liquidia Corporation (LQDA) Stock Analysis: Navigating a 52.88% Potential Upside in the Biotech Sector

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology industry, has been making waves with its innovative approach to treating pulmonary diseases. With a market capitalization of $1.69 billion,..

ARS Pharmaceuticals, Inc. (SPRY): A Biotech Gem with 74% Potential Upside

For investors seeking promising opportunities in the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) stands out with a compelling 74.39% potential upside, according to recent analyst ratings. As a company..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Promising 26.71% Upside in the Medical Instruments Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a distinguished player in the healthcare sector specializing in medical instruments and supplies, has been catching the eye of investors with its robust product portfolio..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds